| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
177,680,000 |
| Market
Cap: |
8.09(B) |
| Last
Volume: |
2,341,048 |
Avg
Vol: |
1,949,015 |
| 52
Week Range: |
$44.82 - $99.04 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 568 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Exact Sciences is a cancer screening and diagnostics company. Co.'s primary screening product, the Cologuard® test, is a non-invasive stool-based DNA screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. Co.'s portfolio of Oncotype tests include: Oncotype DX gene expression tests for breast, prostate and colon cancers; Oncotype DX AR-V7 Nucleus Detect® test, a liquid-based test for advanced stage prostate cancer; and Oncotype MAP™ Pan-Cancer Tissue test (oncomap test), a test delivering tumor profiling to aid therapy selection for patients with metastatic, refractory or recurrent cancer.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
6,762 |
108,398 |
166,494 |
290,334 |
| Total Sell Value |
$463,948 |
$6,570,910 |
$11,277,891 |
$18,676,003 |
| Total People Sold |
8 |
10 |
11 |
11 |
| Total Sell Transactions |
11 |
52 |
61 |
100 |
| End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Condella Sarah |
SVP, Human Resources |
• – – |
2021-06-14 |
4/A |
OE |
$5.03 |
$9,809 |
D/D |
1,950 |
85,932 |
|
- |
|
| Condella Sarah |
SVP, Human Resources |
• – – |
2021-06-11 |
4 |
OE |
$5.03 |
$199,969 |
D/D |
13,102 |
83,982 |
|
- |
|
| Condella Sarah |
SVP, Human Resources |
• – – |
2021-06-10 |
4 |
AS |
$120.00 |
$654,000 |
D/D |
(5,450) |
70,880 |
|
-21% |
|
| Condella Sarah |
SVP, Human Resources |
• – – |
2021-06-10 |
4 |
OE |
$5.03 |
$9,809 |
D/D |
1,950 |
72,830 |
|
- |
|
| Conroy Kevin T |
President and CEO |
• • – |
2021-06-01 |
4 |
AS |
$111.00 |
$1,374,624 |
D/D |
(12,384) |
745,112 |
|
-12% |
|
| Conroy Kevin T |
President and CEO |
• • – |
2021-05-03 |
4 |
AS |
$131.09 |
$2,522,172 |
D/D |
(19,240) |
757,496 |
|
-17% |
|
| Coward D Scott |
Chief Administrative Officer |
• – – |
2021-04-30 |
4 |
A |
$64.74 |
$21,235 |
D/D |
328 |
1,629 |
|
- |
|
| Elliott Jeffrey Thomas |
Chief Financial Officer |
• – – |
2021-04-30 |
4 |
A |
$103.22 |
$21,263 |
D/D |
206 |
38,567 |
|
- |
|
| Condella Sarah |
SVP, Human Resources |
• – – |
2021-04-30 |
4 |
A |
$64.74 |
$21,235 |
D/D |
328 |
74,380 |
|
- |
|
| Conroy Kevin T |
President and CEO |
• • – |
2021-04-30 |
4 |
A |
$64.74 |
$21,235 |
D/D |
328 |
776,736 |
|
- |
|
| Clancy Paul J |
Director |
– • – |
2021-03-18 |
4 |
A |
$0.00 |
$0 |
D/D |
2,929 |
2,929 |
|
- |
|
| Lidgard Graham Peter |
Chief Science Officer |
• – – |
2021-03-11 |
4 |
AS |
$130.00 |
$5,621,330 |
D/D |
(43,241) |
38,367 |
|
-10% |
|
| Lidgard Graham Peter |
Chief Science Officer |
• – – |
2021-03-11 |
4 |
OE |
$21.68 |
$1,126,926 |
D/D |
43,241 |
81,608 |
|
- |
|
| Lidgard Graham Peter |
Chief Science Officer |
• – – |
2021-03-08 |
4 |
OE |
$21.68 |
$99,988 |
D/D |
4,612 |
38,367 |
|
- |
|
| Lidgard Graham Peter |
Chief Science Officer |
• – – |
2021-03-05 |
4 |
AS |
$121.33 |
$1,423,808 |
D/D |
(11,735) |
33,755 |
|
-8% |
|
| Coward D Scott |
Chief Administrative Officer |
• – – |
2021-03-03 |
4 |
AS |
$135.02 |
$359,693 |
D/D |
(2,664) |
1,301 |
|
-10% |
|
| Elliott Jeffrey Thomas |
Chief Financial Officer |
• – – |
2021-03-03 |
4 |
AS |
$135.02 |
$355,373 |
D/D |
(2,632) |
38,361 |
|
-10% |
|
| Lidgard Graham Peter |
Chief Science Officer |
• – – |
2021-03-02 |
4 |
AS |
$138.42 |
$349,372 |
D/D |
(2,524) |
45,490 |
|
-15% |
|
| Elliott Jeffrey Thomas |
Chief Financial Officer |
• – – |
2021-03-02 |
4 |
AS |
$138.42 |
$588,989 |
D/D |
(4,230) |
40,993 |
|
-15% |
|
| Condella Sarah |
SVP, Human Resources |
• – – |
2021-03-02 |
4 |
AS |
$138.42 |
$232,407 |
D/D |
(1,679) |
74,052 |
|
-15% |
|
| Coward D Scott |
Chief Administrative Officer |
• – – |
2021-03-02 |
4 |
AS |
$138.42 |
$574,457 |
D/D |
(4,126) |
3,965 |
|
-15% |
|
| Conroy Kevin T |
President and CEO |
• • – |
2021-03-02 |
4 |
AS |
$138.42 |
$1,355,962 |
D/D |
(9,796) |
799,163 |
|
-15% |
|
| Lidgard Graham Peter |
Chief Science Officer |
• – – |
2021-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,025 |
48,014 |
|
- |
|
| Elliott Jeffrey Thomas |
Chief Financial Officer |
• – – |
2021-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,025 |
45,223 |
|
- |
|
| Condella Sarah |
SVP, Human Resources |
• – – |
2021-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,525 |
75,731 |
|
- |
|
957 Records found
|
|
Page 12 of 39 |
|
|
2.10 (4.83%) 
